Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 2

Sponsor Class

NETWORK 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Pancreatic Neoplasms 18Prostatic Neoplasms 11Carcinoma, Hepatocellular 8Liver Neoplasms 7Neoplasm Metastasis 3Melanoma 3Lung Neoplasms 3Head and Neck Neoplasms 3Colorectal Neoplasms 3Unresectable Pancreatic Cancer 2Stomach Neoplasms 2Squamous Intraepithelial Lesions 2Neoplasms 2Lymphatic Metastasis 2Locally Advanced Pancreatic Cancer 2Kidney Neoplasms 2Cholangiocarcinoma 2Carcinoma, Renal Cell 2Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Urinary Bladder Neoplasms 1Ureteral Neoplasms 1Triple Negative Breast Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumor Including Thyroid, Bone, Liver, Pancreas 1Small Cell Lung Carcinoma 1Skin Neoplasms 1Rectal Neoplasms 1Pancreatic Ductal Adenocarcinoma 1Pancreatic Adenocarcinoma Resectable 1

Interventions

VGX-3100 4Light Coagulation 3DNA Methylation 3Colposcopy 3Biopsy 3Watchful Waiting 2Polymerase Chain Reaction 2Observation 2Laser Therapy 2Imiquimod 2Fluorouracil 2Electroporation 2Cidofovir 2Aminolevulinic Acid 24,4'-dihydroxybenzophenone-2,4-dinitrophenylhydrazone 2epigallocatechin gallate 1calcipotriene 1Solutions 1Restraint, Physical 1Red Light 1Radiofrequency Ablation 1Probiotics 1Mindfulness-Based Stress Reduction 1Megestrol Acetate 1Mass Screening 1Immunohistochemistry 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1Human Papillomavirus DNA Tests 1Histological Techniques 1Gene Expression Profiling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Squamous Intraepithelial Lesions × Electroporation × Clear all
NCT03603808 2026-05-08

VGX-3100 and Electroporation in Treating Patients With HIV-Positive High-Grade Anal Lesions

AIDS Malignancy Consortium

Phase 2 Completed
44 enrolled 15 charts
Gynecologic

Squamous Intraepithelial Lesions, HIV Seropositivity

NCT03185013 2023-07-27

REVEAL 1

Inovio Pharmaceuticals

Phase 3 Completed
201 enrolled 23 charts
Gynecologic

Squamous Intraepithelial Lesions, Uterine Cervical Dysplasia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡